No Data
No Data
Veracyte(VCYT.US) Director Sells US$243.6K in Common Stocks
$Veracyte(VCYT.US)$ Director JONES EVAN/ FA sold 10,000 shares of Common Stocks on Mar 1, 2024 at an average price of $24.3599 for a total value of $243.6K.Source: Announcement What is statement of ch
Veracyte Files Automatic Mixed Securities Shelf
Cathie Wood's Ark Invest Dumps $17M In Coinbase Shares As The Exchange Grappled With Disruption Amid Bitcoin Rally
On Wednesday, Cathie Wood-led Ark Invest made a significant move by selling over $17 million worth of Coinbase Global Inc (NASDAQ:COIN) shares. This decision came as the cryptocurrency exchange faced
Cathie Wood's Ark Invest Sheds $9.3M Worth Of Coinbase Shares Amid Bitcoin Rally — Robinhood Stock Also Sold
On Tuesday, Cathie Wood-led Ark Invest adjusted its portfolio, making significant trades. Among these, the firm's decision to sell $9.3 million worth of Coinbase Global Inc (NASDAQ:COIN) shares stood
Veracyte's Decipher Prostate Test Receives Highest Evidence-Level Rating Among Molecular Tests in Updated Prostate Cancer NCCN Guidelines
Veracyte, Inc. (NASDAQ:VCYT), a leading cancer diagnostics company, today announced that its Decipher Prostate Genomic Classifier is the only gene expression test to receive a "Level 1B" evidence rating in the 2024
Analysts' Top Healthcare Picks: BioCryst (BCRX), Veracyte (VCYT)
No Data